Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating multi-slice ptychography tomography for X-ray imaging.

Optics express·2026
Same author

Triple threat bismuth peptide imaging in cells.

Chemical science·2026
Same author

The nature of thallium crystals in Brassica oleracea (kale): a synchrotron multi-technique investigation.

Metallomics : integrated biometal science·2026
Same author

Multifunctional bending magnet beamline with a capillary optic for X-ray fluorescence studies of metals in tissue sections.

Journal of synchrotron radiation·2026
Same author

XFM and HERFD-XAS studies of selenium in tissues and whole blood from mice supplemented with potentially therapeutic selenocompounds.

Redox report : communications in free radical research·2026
Same author

EXAFS Analysis of Ru265 and Ru360 in Human Blood.

Inorganic chemistry·2026

相关实验视频

Updated: Jul 19, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

通过选择性向白血病细胞来优化治疗.

Judith A Carrall1, Wilford Lie1, Jacob M Lambert1,2

  • 1School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong 2522, New South Wales, Australia.

Journal of medicinal chemistry
|August 18, 2023
PubMed
概括

研究人员开发了新的-复合物来向白血病,显著降低了对健康细胞的毒性. 这一突破为白血病患者提供了更有效,更安全的治疗方法.

更多相关视频

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.1K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.3K

相关实验视频

Last Updated: Jul 19, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.1K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.3K

科学领域:

  • 在瘤学瘤学.
  • 纳米技术纳米技术
  • 药用化学 医学化学

背景情况:

  • 三氧化物已被批准用于急性前兆细胞白血病.
  • 在其他白血病中显示出潜在的作用,但对正常细胞有毒作用.
  • 有针对性的药物输送可以减轻的毒性.

研究的目的:

  • 设计和开发的瘤定位复合体.
  • 为了创造一种针对白血病的治疗剂.
  • 为了减少基癌症治疗的剂量和副作用.

主要方法:

  • 新型-复合物的合成和表征.
  • 合成复合物的稳定性研究.
  • 对白血病和人类血细胞的细胞毒性的体外评估.

主要成果:

  • 成功合成了一种针对白血病的新一类-复合物.
  • 最稳定的复合体对白血病细胞的毒性比人类血细胞大1000倍.
  • 这些发现表明有针对性治疗的巨大潜力.

结论:

  • -复合物为瘤向治疗提供了一个有前途的策略.
  • 这种方法可能会导致系统毒性降低和改善患者的治疗结果.
  • 进一步的体内研究是有必要的,以验证治疗潜力.